Barrington Believes NTRI Won’t Stop Here

By Ryan Adsit

Barrington analyst Matthew Gall reiterated a Buy rating on Nutrisystem Inc (NASDAQ: NTRI) today and set a price target of $37. The company’s shares opened today at $31.45, close to its 52-week high of $33.60.

Gall has an average return of 42.1% when recommending Nutrisystem Inc.

According to, Gall is ranked #1000 out of 4178 analysts.

Currently, the analyst consensus on Nutrisystem Inc is Moderate Buy and the average price target is $37, representing a 17.6% upside.

In a report issued on October 19, Wunderlich also reiterated a Buy rating on the stock with a $37 price target.

Based on Nutrisystem Inc’s latest earnings report from June 30, the company posted quarterly revenue of $149.8M and quarterly net profit of $16.12M. In comparison, last year the company earned revenue of $104.9M and had a net profit of $7.31M.

Based on the recent corporate insider activity of 32 insiders, corporate insider sentiment is neutral on the stock. Most recently, in August 2016, Jay Herratti, a Director at NTRI sold 2,880 shares for a total of $83,693.

Nutrisystem, Inc. engages in the provision of weight management system. It involves in the manufacture and distribution of low-calorie, portion controlled prepared meal ranging from breakfast, lunch, dinner, snacks and shakes. It also provides balanced weight loss programs designed for women, men and seniors as well as for people with diabetes in reducing and managing their diabetes. The company was founded in 1971 and is headquartered in Fort Washington, PA.